A Bioequivalence Study of Amlitelimab Delivered by 2 Different Devices in Healthy Adult Participants
Clinical trial NCT07146750 · COMPLETED
Trial details
- NCT number
- NCT07146750
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-25
- Primary completion
- 2026-04-08
- Enrollment
- 212
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.